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In this editorial space four years ago, we discussed the issues concerning the editorial policy of the 
Brazilian Journal of Pharmaceutical Sciences and since then numerous themes have been addressed; the his-
tory of the publication and its evolution, the adoption of the English language lifting barriers to access, the 
need for involvement of Academia in pursuance of advances in the national indexed periodicals as effective 
vehicles for disseminating its research, the necessary recognition in the international domain, the quality and 
efficiency of the paper appraisal process, the necessary dissemination in the international sphere, open access 
and engagement in democratization of science, ethical conduct in terms of authorship and publication, the 
crucial role of funding bodies, the impact of indexation on growth, and countless other issues. Today how-
ever, despite all these concerns, we got to thinking… And what of quality? Why this striving for quantitative 
indexes? And what about qualitative measures? Clearly, because qualitative measures are more subjective! 
And with this concern in mind, as stated by Reinach, 2013:
There is no doubt that quantitative methods are useful for assessing scientists, but using 
them exclusively while abdicating the subjective capacity of identifying people who are 
talented, creative, or simply geniuses, is a surefire way of excluding the few people that 
can really make groundbreaking discoveries from a scientific career. This attitude exempts 
those responsible from taking and defending decisions. It is intellectual cowardice hidden 
behind mathematic algorithms.”
we ask the question: Would it be that the same applies to the analysis of periodicals? Would it be that the na-
tional Editors should begin questioning their current stance in the quest for indexes? Perhaps the periodicals 
are being assessed in much the same way as scientists, an approach known to lead to practices unfavorable 
for promoting the quality of the science published; the majority of researchers are more concerned with the 
number of papers published, the amount of citations received, and in which high-impact journals they were 
published. Editors, for their part, are more concerned about the impact factors of their publications, which in 
turn leads to a growth in plagiarism, increased self-citations, manipulated citations, the practice of “salami 
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science” - splitting a single investigation into several publications, artificially generating a greater number 
of citations in the academic milieu, uncommendable conduct such as exchange of citations between authors, 
self-citation, self-plagiarism, etc… And reiterating the point, where is the quest for quality? And, as Rein-
ach points out, the aim of science is no longer to understand nature but is gradually becoming about being 
published and cited.
As the executive editor of the Brazilian Journal of Pharmaceutical Sciences I can vouch that our publica-
tion has been free of undesirable citation practices and upon analyzing our annual statistical data released by 
SCImago Journal Rank, can proudly note the negligible number of self-citations. This conduct has garnered 
great respect for our work and, although our indexes have shown a moderate rise (Table I), we remain firm 
in the belief that this growth was based purely on scientific content which, subjected to rigorous peer review, 
has led to the publication of quality articles. We are convinced this is the science we should be promoting!
By contrast, the national periodicals which strive for higher indexes assume the underestimated role of 
providing a channel for the scientific output which has not made it into international journals and, moreover, 
in accordance with the new assessment criteria adopted by the Coordination for the Improvement of Higher 
Education Personnel (CAPES) under a single framework, Brazilian journals compete with international 
periodicals and occupy lower rankings on Qualis, which in turn influence the analysis of the country’s post-
graduate courses. Additionally, there is the matter of studies that although lacking great international appeal, 
are extremely important for furthering ideas and research in their local regions. As aptly put by the researcher 
Vanderlan Bolzani: “the fact you publish in national journals does not mean your work lacks merit or quality”. 
We still recognize however, that we must seek ways of achieving dissemination and impact while 
boosting the credibility of the BJPS in the International scientific community. To this end, we are seeking 
exchange in academic collaborations, an approach evident in our statistics. Parallel to the rise in the number of 
studies published, there is a proportional increase in the number of articles published from abroad. Likewise, 
the number of articles originating from other States in Brazil has also risen. Thus, there is no endogeneity 
and the periodical increasingly represents the Pharmaceutical Sciences carried out in Brazil while steadily 
revealing its international side (Figure 1). The publication of a special edition was planned for this year, a 
goal to be attained shortly through the publication of a special edition on “Dendrimers” which shall carry 
articles of relevance to the field authored by internationally renowned specialists.
At this juncture, it is also pertinent to express our acknowledgement of the need for using the English 
language in the dissemination of science. Four years after adopting the English language as its official vernacu-
lar, the Brazilian Journal of Pharmaceutical Sciences has benefited from greater national and international 
recognition and with this an increased responsibility to meet the quality standards required.
Today, we have set targets for achieving sustainable growth, growth which can undoubtedly be at-
tributed to the journal’s indexation in the main leading Databases such as ISI-Thomson Reuters, Scimago/
Elsevier, SciELO, International Pharmaceutical Abstracts, Scopus among others. The impact factor of the 
BJPS in the Science Citation Index, following its inclusion in 2010 (Table I) and based on statistical data 
released by Scimago/Elsevier, shows a rise to 128 citations within a one-year period, as well as increases in 
the other indexes.
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TABLE I - Impact fator 2010-2012
Year
JCR Data
Total 
Cites
Impact 
Factor
Immediacy 
Index Articles
Cited 
Half-life
Eigenfactor® 
Score
2010 285 0.254 0.000 66 4.8 0.00061
2011 313 0.276 0.059 68 5.4 0.00064
2012 361 0.373 0.000 59 5.5 0.00067
Available at: <http://www.scimagojr.com/journalsearch.php?q=19700182901&tip=sid&clean=0>
Figure 1
Origin of published articles per year
2001-2012
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The 2012 period saw a 45% increase in the number of studies submitted (Figure 2) compared with 
a 42% rise for 2010-2011. This figure reflects the interest in publishing in the BJPS, given its quality and 
recognition via indexation in International databases. The adoption of the Associated Editors system in the 
areas of Drugs and Medications, Pharmaceutical Assistance, Clinical and Toxicological Analyses, and Food 
and Nutrition was a another step toward refining the previous work of co-editing the publication and allowed 
a larger panel of “ad hoc” reviewers with definitions of areas of practice and specialty, aimed at improving 
the efficiency of the publication process. The rigor in appraising the studies submitted, coupled with the ef-
ficiency of the co-editing work, led to the rejection of 86 (eighty-six) articles in 2012, accounting for 32% of 
total articles submitted (Figure 3). This fact reflects the previously outlined pursuance of quality, and even 
with an internationally young collection, we hope to reach the global average for impact factor, confirming 
that ethical conduct does pay off.
It is also worth mentioning that, in agreement with Reinach (2013), there is a pressing need for return 
of innovative thinking, incentives for creativity and logical reasoning. We realize that only gradual growth is 
sustainable and perhaps with this ideology we may one day declare that the Brazilian Journal of Pharmaceutical 
Sciences has published a groundbreaking discovery. Ultimately, the geniuses overlooked by the quantitative 
*Received articles until June, 2013
Figure 2
Submitted articles per year
2001-2013
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process of assessment can see their studies published in periodicals that do not offer major impact but whose 
standing is marked by their ethical conduct.
I would like to extend my thanks to the Scientific Editor of the BJPS, Prof. Elizabeth Igne Ferreira, for 
the opportunity to express these ideas, and trust that these may contribute to the discussion among national 
scientific editors.
 Leila Rangel de Carvalho Aranha
 Executive Editor
 Brazilian Journal of Pharmaceutical Sciences
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